0.3423
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$0.3432
Aprire:
$0.3473
Volume 24 ore:
276.62K
Relative Volume:
0.04
Capitalizzazione di mercato:
$14.22M
Reddito:
$62.71M
Utile/perdita netta:
$-10.48M
Rapporto P/E:
-0.5433
EPS:
-0.63
Flusso di cassa netto:
$-13.77M
1 W Prestazione:
+3.78%
1M Prestazione:
-26.56%
6M Prestazione:
-26.32%
1 anno Prestazione:
-85.47%
Prophase Labs Inc Stock (PRPH) Company Profile
Nome
Prophase Labs Inc
Settore
Industria
Telefono
(215) 345-0919
Indirizzo
711 STEWART AVE, SUITE 200, NEW YORK, PA
Confronta PRPH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PRPH
Prophase Labs Inc
|
0.3423 | 13.94M | 62.71M | -10.48M | -13.77M | -0.63 |
![]()
TMO
Thermo Fisher Scientific Inc
|
484.17 | 185.31B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
204.29 | 148.75B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
638.86 | 51.31B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
118.20 | 33.85B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
187.78 | 31.96B | 15.70B | 1.24B | 2.01B | 6.91 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-12-20 | Iniziato | H.C. Wainwright | Buy |
2021-10-13 | Downgrade | Dawson James | Buy → Neutral |
2021-01-20 | Iniziato | Dawson James | Buy |
Prophase Labs Inc Borsa (PRPH) Ultime notizie
Measuring ProPhase Labs Inc.’s beta against major indices2025 Short Interest & Verified Technical Signals - Newser
Is it too late to sell ProPhase Labs Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser
Technical signs of recovery in ProPhase Labs Inc.2025 Price Targets & Precise Trade Entry Recommendations - Newser
How to track smart money flows in ProPhase Labs Inc.CEO Change & AI Forecasted Entry/Exit Points - Newser
How to integrate ProPhase Labs Inc. into portfolio analysis tools2025 Market Outlook & Weekly High Momentum Picks - Newser
ProPhase Labs Inc. Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - 클래시안
What MACD and RSI say about ProPhase Labs Inc.Market Trend Report & Free Technical Confirmation Trade Alerts - Newser
Why ProPhase Labs Inc. stock attracts strong analyst attentionJuly 2025 Movers & Weekly High Return Opportunities - Newser
Is ProPhase Labs Inc. reversing from oversold territory2025 Major Catalysts & Target Return Focused Picks - Newser
Risk vs reward if holding onto ProPhase Labs Inc.Market Sentiment Report & Real-Time Market Sentiment Alerts - Newser
Intraday pattern recognizer results for ProPhase Labs Inc.Quarterly Profit Review & Detailed Earnings Play Alerts - Newser
What earnings revisions data tells us about ProPhase Labs Inc.Index Update & AI Driven Price Forecasts - Newser
Real time scanner hits for ProPhase Labs Inc. explainedMarket Trend Summary & Entry Point Confirmation Alerts - Newser
ProPhase Labs Inc. Breakout Confirmed by Volume MetricsJuly 2025 Trade Ideas & Free Accurate Trade Setup Notifications - 더경남뉴스
Has ProPhase Labs Inc. found a price floorEarnings Miss & AI Forecast Swing Trade Picks - Newser
What’s the RSI of ProPhase Labs Inc. stockJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - theviewers.co.kr
Does ProPhase Labs Inc. show high probability of reboundPortfolio Update Summary & Daily Stock Trend Watchlist - Newser
What makes ProPhase Labs Inc. stock price move sharply2025 Sector Review & Low Risk High Reward Ideas - Newser
Evaluating ProPhase Labs Inc. with trendline analysis2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
ProPhase Labs Inc. Recovery Hinges on Volume BreakoutJuly 2025 Final Week & Community Supported Trade Ideas - 더경남뉴스
ProPhase Labs announces closing of $3M senior secured convertible notes - MSN
ProPhase Labs Receives SEC Approval for Special Meeting, Increases Authorized Shares to 1B - AInvest
ProPhase Labs, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:PRPH) - Seeking Alpha
ProPhase Labs Achieves Key U.S. Patent for Test - MSN
Strategies to average down on ProPhase Labs Inc.Trade Ideas & Free Safe Entry Trade Signal Reports - Newser
Prophase Labs Files Proxy, Reschedules Shareholder Meeting - TipRanks
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders - GlobeNewswire
ProPhase Labs Announces New Date for Special Meeting of Shareholders. - AInvest
1 Billion Shares: ProPhase Labs Plans Major Expansion into Bitcoin Strategy and $15M Buyback Program - Stock Titan
Sentiment analysis tools applied to ProPhase Labs Inc.Weekly Market Summary & Advanced Technical Analysis Signals - Newser
Analyzing drawdowns of ProPhase Labs Inc. with statistical toolsInsider Buying & Real-Time Buy Signal Notifications - Newser
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects - Yahoo Finance
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects By GuruFocus - Investing.com Canada
Prophase Labs, Inc. shares fall 8.11% premarket as federal budget cuts and VC funding into oncology ventures. - AInvest
What is ProPhase Labs Inc. s revenue forecastJuly 2025 Intraday Action & Daily Market Momentum Tracking - 선데이타임즈
Why did PRPH's Q4 2024 earnings surprise analysts? - AInvest
Volume Surge May Signal Institutional Interest in ProPhase Labs Inc.Trade Risk Assessment & Free AI Powered Buy and Sell Recommendations - sundaytimes.kr
Can ProPhase Labs Inc. deliver alphaCPI Data & Precise Swing Trade Alerts - thegnnews.com
ProPhase Labs announces full USPTO approval for issuance of U.S. patent - MSN
Price Channel Expanding on ProPhase Labs Inc.’s ChartTrade Ideas & Daily Entry Point Trade Alerts - beatles.ru
Prophase Labs shares rise 2.14% intraday after earnings results presentation. - AInvest
ProPhase Labs 2025 Q2 Earnings Improved Losses Despite Revenue Decline - AInvest
ProPhase Labs Reports Turnaround and Strategic Growth - TipRanks
ProPhase Labs Q2 2025 Earnings Call Transcript - MarketBeat
ProPhase Labs' Q2 2025: Unraveling Contradictions in Cancer Test Strategies and Crypto Investments - AInvest
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Prophase Labs Inc Azioni (PRPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):